Product NDC: | 60432-606 |
Proprietary Name: | Promethazine and Codeine |
Non Proprietary Name: | Promethazine hydrochloride and Codeine phosphate |
Active Ingredient(s): | 10; 6.25 mg/5mL; mg/5mL & nbsp; Promethazine hydrochloride and Codeine phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60432-606 |
Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088875 |
Marketing Category: | ANDA |
Start Marketing Date: | 19841217 |
Package NDC: | 60432-606-16 |
Package Description: | 473 mL in 1 BOTTLE (60432-606-16) |
NDC Code | 60432-606-16 |
Proprietary Name | Promethazine and Codeine |
Package Description | 473 mL in 1 BOTTLE (60432-606-16) |
Product NDC | 60432-606 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Promethazine hydrochloride and Codeine phosphate |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 19841217 |
Marketing Category Name | ANDA |
Labeler Name | Morton Grove Pharmaceuticals, Inc. |
Substance Name | CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE |
Strength Number | 10; 6.25 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |